Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
community to learn, collaborate, and discover. They will seek to fundamentally and radically advance our understanding of Natural and Artificial Intelligence. We seek candidates with demonstrated ability and
-
the effective use of information technology. We are recruiting an IT workforce that has both breadth in their ability to collaborate and innovate across disciplines – and depth in specific areas
-
the study protocol: https://link.springer.com/article/10.1186/s12888-025-07030-9?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20250730&utm_content=10.1186%2Fs12888-025-07030-9 BRIDGE-AI will
-
, neurophysiology, and behavioral assays Proficiency in molecular biology techniques such as cloning, PCR, and genotyping A strong sense of independence, with the ability to manage and lead scientific projects
-
our work, grow professionally, and aim for the extraordinary Learn more about Financial Administration (harvard.edu) and our eight reporting units. (https://finance.harvard.edu/) Job Description The
-
. Additional Qualifications: Applicants must have a strong background in advanced mathematics. Essential qualities include initiative, good judgment, and the ability to work well on a team. Special Instructions
-
the effective use of information technology. We are recruiting an IT workforce that has both breadth in their ability to collaborate and innovate across disciplines – and depth in specific areas
-
the effective use of information technology. We are recruiting an IT workforce that has both breadth in their ability to collaborate and innovate across disciplines – and depth in specific areas
-
Pharmacology (LSP) and Program in Therapeutic Science (https://labsyspharm.org/ ) at Harvard Medical School (HMS) in Boston, Massachusetts. A successful candidate will have a biology and/or information
-
visit: https://causalab.sph.harvard.edu/. This role is focused on pregnancy research: To evaluate the effects of treatments in pregnancy we emulate target trials using observational large healthcare